BCM
VXRT

Bayesian Capital Management’s Vaxart VXRT Stock Holding History

Bayesian Capital Management’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-11,300
Closed -$68K – 665
2021
Q1 		$68K Sell
11,300
-20,500
-64% -$158K 0.02% 503
2020
Q4 		$182K Buy
+31,800
New +$202K 0.05% 391

Other funds holding VXRT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Bayesian Capital Management's VXRT Position: Q2 2021 in Review

Bayesian Capital Management sold out of Vaxart (VXRT) in Q2 2021, closing a stake of 11,300 shares — an estimated $68K sold.

Bayesian Capital Management first reported a position in VXRT in Q4 2020 and held it in 2 quarters. The position peaked at $182K in Q4 2020. 143 funds tracked by Wall St. Rank hold VXRT as of Q2 2021.

  • Bayesian Capital Management reported no remaining Vaxart position as of Q2 2021 after selling out during the quarter.
  • Bayesian Capital Management sold 11,300 Vaxart shares in Q2 2021, an estimated $68K.
  • Bayesian Capital Management first reported a position in Vaxart in Q4 2020 and held it in 2 quarters.
  • Bayesian Capital Management's Vaxart position peaked at $182K in Q4 2020.
  • 143 funds tracked by Wall St. Rank held Vaxart as of Q2 2021.

Based on Bayesian Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.